Heart Failure

Cardiovascular Clinical Consult

Adult Immunization

Hepatic Disease 

Behcet’s Disease

Rare Disorders

Pediatric Immunization

Implementing The Topcon Ocular Telehealth Platform

Weight Management

Monkeypox

Guidelines

Men's Health

Panic Disorder  

Anxiety

Eating Disorders

Depression

Substance-related Disorders

ADHD

Psychiatry 

Seasonal Allergies

Allergy

Nutrition 

Pregnancy and Birth

Women's Health

Atrial Fibrillation

Cholesterol Disorders

Cardiovascular Disease

Hypertension

Cardiology

Substance Use

Child/Adolescent

Pediatrics

Kidney Disease

Genetics

Medical Cannabis

Complimentary & Alternative Medicine

Skin Diseases

Dermatology

Thyroid Disorders 

Diabetes

Diabetes Type 2

Insulin

Endocrinology 

Oral Medicine 

Otorhinolaryngologic Diseases

Fibromyalgia

Pain

Irritable Bowel Syndrome 

Inflammatory Bowel Disease

Gastrointestinal Disorders

Geriatrics

Coronavirus

Hepatitis C

Cold, Cough, and Flu

Bacterial Conjunctivitis

Immunization

Influenza

HIV AIDS

Sexually Transmitted Diseases

Infection

Osteoporosis

Imaging 

Musculoskeletal Disorders  

Obesity

Rheumatoid Arthritis

Arthritis

Gout

Rheumatology

Technology

Colorectal Cancer

Kidney Cancer

Lung Cancer

Melanoma

Skin cancer

Prostate Cancer

Breast Cancer

Cervical Cancer

Cancer

Nephrology

Anemia

Dementia

Epilepsy

Cerebrovascular Diseases

Headache and Migraine

Parkinson Disease

Alzheimer disease

Stroke

Mental Health

Headache

Migraine

Nervous System Diseases

Sleep Disorders

Neurology

Asthma

Cystic Fibrosis

COPD

Pneumonia

Respiratory Diseases

Pulmonology

News

All News

Office Procedures

Practice Management

Media

Around the Practice

Between the Lines

ConsultantLive

Expert Interviews

Institutional Insights

Medical World News

Podcasts

Primary View

Provider Toolkits

Readout360

Conferences

Conference Coverage

Conference Listing

Resources

Image IQ

Interactive Posters

Polls

Publications

Quizzes

Subscribe

CE/CME

Advertise

Contact Us

Terms and Conditions

Privacy

Do Not Sell My Information

Patient Care Online

Twitter

Facebook

LinkedIn

Clinical Focus

Allergy & Immunology

Endocrinology

Gastroenterology

Infectious Disease

Men’s Health

Pain Management

Psychiatry

Women’s Health

Business Focus

Billing and Collections

Career Planning

Coding and Documentation

Concierge Medicine

Cybersecurity

EHRs

Investing

Patient Relations

Personal Finance

Remote Patient Monitoring

Staffing

Telehealth

Value-based Care

Spotlight

Unmet Needs in Managing MDD

Interpreting Thyroid Function Tests

Using Thyroid Lab Tests

Testing & Screening to Optimize Men's Health

1rem

Clinical Topics

Topics

, Shagun Bindlish, MD, and Peminda K. Cabandugama, MD, discuss obesity and type 2 diabetes (T2D), including the most significant complications associated with these conditions that a primary care clinician is likely to encounter, how to best treat patients with obesity and T2D, and their suggestions to primary care clinicians on managing this patient population.

Dr Bindlish is a board member of the American Diabetes Association and medical director at One Medical in Dublin, California. 

Dr Cabandugama is the director of Digital Obesity at the Cleveland Clinic and a member of the Obesity Medicine Association.

 podcast features informative conversations with health care experts, opinion leaders, and practicing physicians, about what impacts primary care medicine today. 

 to subscribe on your favorite streaming service.

In our latest episode, 2 obesity experts discuss the importance of early intervention to reduce risk for complications, suggestions for managing patients in primary care, and more.

Obesity & Type 2 Diabetes: An Expert Discussion

The Primary Viewpoints podcast features informative conversations with health care experts, opinion leaders, and practicing physicians, about what impacts primary care medicine today.

In episode 17, Dr Hiddo Heerspink, joins us to discuss findings he recently presented at the American Diabetes Association 2022 Scientific Sessions from a 

 he led of the SURPASS-4 clinical trial of tirzepatide that looked for the first time at the effects of the novel GLP-1 receptor agonist on kidney function in patients with type 2 diabetes.

Hiddo Heerspink, PhD, PharmD, is professor of clinical trials and personalized medicine and a clinical pharmacologist/trialist in the department of clinical pharmacy and pharmacology at the University Medical Center Groningen in Groningen, Netherlands; he is also Codirector of the Better Treatments Program at the George Institute for Global Health in Newtown, Australia.

 to subscribe to the Primary Viewpoints podcast. Be sure to leave a rating and review for the show. Thanks for listening!

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Hiddo Heerspink, PhD, PharmD. 

Episode 17: Kidney Outcomes with Tirzepatide in Type 2 Diabetes

Results of a large prospective study on the health effects of coffee have significantly amplified the social buzz about America’s favorite morning beverage. The findings, published in the 

are somewhat contrary to popular beliefs about drinking multiple cups of coffee a day.

Based on data collected by the National Institutes of Health on the coffee-drinking habits of more than 400,000 men and women, the report found that frequent coffee drinkers have a lower risk of dying of a variety of diseases, compared with people who drink little or no coffee.

In fact, inverse associations were observed for deaths as a result of heart disease, respiratory disease, stroke, diabetes, and infections.

The good news is making headlines in media of all forms and you’re likely to get questions from your patients.

• How strong was the association between amount of coffee consumed and a decreased risk of mortality? Was it stronger for some causes of death than for others?
• What other lifestyle habits were associated with coffee consumption that may have had an effect on the results?
• What components in coffee might be responsible for apparent salutary effects on the body and particularly on the cardiovascular and endocrine systems?

Here to put this issue into perspective are Drs Christopher Cannon and Payal Kohli. Dr Cannon, a senior investigator with the TIMI Study Group, is Editor-in-Chief of 

. He is also Professor of Medicine at Harvard Medical School and Associate Physician in the Cardiovascular Division of Brigham and Women’s Hospital in Boston. Dr Kohli graduated from Harvard Medical School, completed her internal medicine training in Boston and is currently a fellow in cardiovascular medicine at the University of California San Francisco.


Freedman ND, Park Y, Abnet CC, et al. Association of coffee drinking with total and cause-specific mortality. 

Frequent coffee drinkers have a lower risk than those who drink little or no coffee, of death related to heart and respiratory disease, stroke, and infections.

Frequent Coffee Consumption Linked to Longevity: Caffeine Buzz

Results also showed that older adults, men, and Black adults face an increased risk of advanced stages of CKM syndrome. 

Poor Cardiovascular-Kidney-Metabolic Health “Widespread” among US Adults, According to New Study

Your daily dose of the clinical news you may have missed.

Adults with Prior Antiobesity Medication Use Before Semaglutide Use Lose More Weight: Daily Dose

The national study on the true prevalence of metabolic dysfunction-associated liver disease is essential to screening, prevention, and treatment efforts, says AFL CEO Stiehl. 

American Liver Foundation Announces First Federally-Funded Research on MASLD

Adults receiving semaglutide for the first time achieved weight loss of 14.3% at 12 months vs 10.6% among those who had previously taken a different antiobesity drug. 

Adults with Obesity Who Receive Semaglutide as First Weight Loss Medication Lose More Weight

Elevated Lp(a) Level Raises ASCVD Risk Regardless of Age, Sex, Race/Ethnicity: Daily Dose

Diabetes technology - it's a jungle out there for clinicians who aren't familiar with the myriad devices and features or who have some experience with one particular system for a few patients but want to know more about others available and how they compare. Even for clinicians who have experience with a range of devices and types, an unbranded, unabiased tool for quick comparison would be helpful. 

These are the "user groups" Stanford University's Korey Hood, PhD and team had in mind when they designed DiabetesWise Pro, a new one-stop diabetes device comparison tool launched in April. Hood spoke with PatientCare Online recently about the knowledge gaps and range of comfort levels he and his team identified among clinicians when it comes to recommending diabetes technology. 

Compare, contrast, price shop, prescribe. DiabetesWise Pro developer Korey Hood, PhD, highlights the tool all primary care clinicians should try. 


Diabetes Device Comparison Made Easy: The Story Behind DiabetesWise Pro

Endocrinology

Latest News